评估6PPD-Q在斑马鱼中的生物可用性和生物转化,通过薄膜中的扩散梯度
Suyu Ren1, Yuxiang Xia1, Mengfei Wang1
1School of Environmental and Material Engineering, Yantai University, Yantai 264005, China.
Environmental research
|January 23, 2026
概括
薄膜扩散梯度 (DGT) 技术准确地预测了斑马鱼的6PPD-Q生物可用性,克服了传统方法的局限性. 此外,DGT还有效地监测6PPD-Q代谢物,为环境行为提供新的见解.
科学领域:
- 环境化学环境化学
- 水生毒理学 水生毒理学
- 分析化学 分析化学
背景情况:
- 评估6PPD-Q的生物可用性对于了解其在水生生态系统中的生物积累和环境风险至关重要.
- 对于6PPD-Q的传统生物分析方法在效率和现场应用方面面临挑战.
- 6PPD-Q是一种对环境有害的物质,可能对水生生物产生影响.
研究的目的:
- 评估在薄膜 (DGT) 技术中扩散梯度的新型应用,以预测斑马鱼 (Danio rerio) 中的6PPD-Q生物可用性.
- 将DGT的有效性与直接的生物采样进行比较,以评估6PPD-Q及其代谢物.
- 研究斑马鱼中6PPD-Q的生物积累和生物转化,并描述其代谢物释放动力学.
主要方法:
- 斑马鱼和DGT设备同时暴露在不同度的6PPD-Q溶液中 (5-100μg L-1).
- 使用高分辨率液体染色体质谱法识别和量化6PPD-Q及其代谢物在斑马鱼和溶液中.
- 分析DGT测量和斑马鱼6PPD-Q度之间的相关性.
主要成果:
- DGT精确地确定了6PPD-Q的时间加权平均度,即使水平波动.
- 在DGT测量和斑马鱼度在环境相关水平 (1.90-20.8μg L-1) 之间观察到强烈的正相关性 (R2=0.786-0.996).
- 在斑马鱼中确定了四种6PPD-Q代谢物,DGT有效地捕获了它们的微量级动态和释放动态,表现优于直接采样.
结论:
- DGT技术是预测斑马鱼等水生生物体中6PPD-Q生物利用性的可靠工具.
- 与传统方法相比,DGT为检测疏水性有机污染物及其代谢物提供了更高的灵敏度和动力分析.
- 这项研究开创了DGT应用程序,用于评估6PPD-Q的生物可用性和代谢物释放,为其环境行为提供了关键的见解.
相关概念视频
Diffusion
217.1K
Diffusion is the passive movement of substances down their concentration gradients—requiring no expenditure of cellular energy. Substances, such as molecules or ions, diffuse from an area of high concentration to an area of low concentration in the cytosol or across membranes. Eventually, the concentration will even out, with the substance moving randomly but causing no net change in concentration. Such a state is called dynamic equilibrium, which is essential for maintaining overall...
217.1K
What is an Electrochemical Gradient?
127.5K
Adenosine triphosphate, or ATP, is considered the primary energy source in cells. However, energy can also be stored in the electrochemical gradient of an ion across the plasma membrane, which is determined by two factors: its chemical and electrical gradients.
The chemical gradient relies on differences in the abundance of a substance on the outside versus the inside of a cell and flows from areas of high to low ion concentration. In contrast, the electrical gradient revolves around an...
The chemical gradient relies on differences in the abundance of a substance on the outside versus the inside of a cell and flows from areas of high to low ion concentration. In contrast, the electrical gradient revolves around an...
127.5K
Drug Biotransformation: Overview
3.7K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
3.7K
Drug Biotransformation: Overview
2.5K
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
2.5K
Factors Affecting Drug Biotransformation: Biological
533
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
533
Bioavailability Study Design: Absolute Versus Relative Bioavailability
322
Bioavailability is a crucial pharmacokinetic parameter that quantifies the proportion of an administered drug that reaches the systemic circulation and is available for therapeutic action. Regulatory agencies mandate the assessment of bioavailability, typically measured as the area under the drug plasma concentration-versus-time curve (AUC), to ensure the efficacy and safety of pharmaceutical products. These evaluations are categorized as absolute and relative bioavailability studies.Absolute...
322


